Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT-877 in Healthy Subjects
Status:
Completed
Trial end date:
2019-11-24
Target enrollment:
Participant gender:
Summary
This clinical trial is the first-in-human study of BBT-877. The purpose of this phase 1 study
is to assess the safety and tolerability of single and multiple ascending oral doses of
BBT-877 in healthy adult subjects.